May 4, 2007
Pergolide Availability: No FDA Announcement, Supplies Running Low
More than a month since pergolide mesylate, a drug commonly used to treat pituitary pars intermedia dysfunction (PPID), also known as equine Cushing’s disease, was withdrawn for human use, the FDA has yet to make an announcement on whether it will allow…
